Literature DB >> 26055547

Rheumatoid arthritis: Manipulating the FLS 'proteoglycan switch' could offer a new approach to RA therapy.

Sarah Onuora.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26055547     DOI: 10.1038/nrrheum.2015.78

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.

Authors:  Karen M Doody; Stephanie M Stanford; Cristiano Sacchetti; Mattias N D Svensson; Charlotte H Coles; Nikolaos Mitakidis; William B Kiosses; Beatrix Bartok; Camille Fos; Esther Cory; Robert L Sah; Ru Liu-Bryan; David L Boyle; Heather A Arnett; Tomas Mustelin; Maripat Corr; Jeffrey D Esko; Michel L Tremblay; Gary S Firestein; A Radu Aricescu; Nunzio Bottini
Journal:  Sci Transl Med       Date:  2015-05-20       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.